One way to advocate to policymakers in Sacramento and Washington D.C. is for them to hear more stories of how the biomedical community has impacted lives. Share how the biomedical innovation in California has been critical to your wellbeing below. Together, we can continue protecting biomedical innovation in California and around the world.
It is incredibly rewarding to call companies like @LillyPad members of CLSA.
Innovation, collaboration, & determination have defined the fight against the COVID pandemic....and innovation is winning.
Science always wins.
Thank you!! https://t.co/JUZ4gnmaw4
Lilly has reached an agreement with the U.S. government to provide an investigational neutralizing antibody for the treatment of mild to moderate #COVID19 illness in high-risk patients, pending emergency use authorization. Read more: https://t.co/39rYMMVM3Q https://t.co/VxEzhtIPsj
CLSA - California Life Sciences Association